Notably, our group has recently shown that ODC inhibition turns toxic severe reactive astrocytes into beta-amyloid (Aβ)-detoxifying astrocytes in Alzheimer’s disease (AD) model and raised ODC inhibition as a promising therapeutic strategy for AD.6 Here, ODC1 is linked to Alzheimer disease.